KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Free Cash Flow (2016 - 2026)

Supernus Pharmaceuticals has reported Free Cash Flow over the past 15 years, most recently at $19.4 million for Q4 2025.

  • Quarterly Free Cash Flow fell 56.02% to $19.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $46.0 million through Dec 2025, down 73.14% year-over-year, with the annual reading at $46.0 million for FY2025, 73.14% down from the prior year.
  • Free Cash Flow was $19.4 million for Q4 2025 at Supernus Pharmaceuticals, up from -$61.8 million in the prior quarter.
  • Over five years, Free Cash Flow peaked at $71.1 million in Q2 2022 and troughed at -$61.8 million in Q3 2025.
  • The 5-year median for Free Cash Flow is $36.0 million (2021), against an average of $28.6 million.
  • Year-over-year, Free Cash Flow surged 1201.57% in 2023 and then plummeted 215.89% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $48.8 million in 2021, then crashed by 43.13% to $27.7 million in 2022, then surged by 62.25% to $45.0 million in 2023, then fell by 1.78% to $44.2 million in 2024, then crashed by 56.02% to $19.4 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Free Cash Flow are $19.4 million (Q4 2025), -$61.8 million (Q3 2025), and $58.1 million (Q2 2025).